Top Ten Common Prejudices About Polyethylene Naphthalate Market.

The global catheters market is expected to grow at an annual rate of 8.7% from USD 15.9 billion in 2020 to USD 24.2 billion in 2025. Catheters are in high demand due to the growing target patient population and the growing preference for less invasive surgical treatments over traditional surgery. Product failures and recalls, as well as adverse taxation policies and trade obstacles, are projected to stifle this market's growth over the projection period.
Angiography catheters, IVUS/OCT catheters, guiding catheters, electrophysiology catheters, and balloon catheters are the several types of cardiovascular catheters. Electrophysiology catheters accounted for the majority of the cardiovascular market in 2019. The increasing frequency of atrial fibrillation (AF) and the growing geriatric population are the main reasons behind this.
The catheters market is divided into hospitals, long-term care facilities, diagnostic imaging centres, and other end users based on end user. The largest share of the market in 2019 was held by hospitals. During the projection period, this segment is also expected to increase at the fastest CAGR. Factors such as the rising prevalence of CVD, urine incontinence, and other chronic diseases, and the resulting growth in the number of patients around the world, leading to a growing demand for hospital care, are responsible for this segment's huge share and high CAGR.
The catheters market is divided into hospitals, long-term care facilities, diagnostic imaging centres, and other end users based on end user. The largest share of the market in 2019 was held by hospitals. During the projection period, this segment is also expected to increase at the fastest CAGR. Factors such as the rising prevalence of CVD, urine incontinence, and other chronic diseases, and the resulting growth in the number of patients around the world, leading to a growing demand for hospital care, are responsible for this segment's huge share and high CAGR.
In 2018, Becton, Dickinson and Company (BD) (US) was a major player in the intravenous market. This is due to its diverse product offering and strong geographic presence. BD focuses on producing new goods to maintain its leadership position. BD's products are made and sold all over the world. Its products are sold through direct sales and independent distribution channels in the United States and overseas.
BTG plc was bought by Boston Scientific Corporation in 2019. (UK). Boston Scientific's product options for minimally invasive procedures targeting cancer and vascular illnesses, as well as specialised medications, were enhanced as a result of this acquisition.
The Telescope Guide Extension Catheter was introduced by Medtronic in 2019.
TVA Medical, Inc. was bought by Becton, Dickinson and Company (BD) in 2018. (US). TVA Medical's dialysis catheters, drug-coated balloons, conventional angioplasty balloons, and endovascular stent graft devices were added to BD's product range as part of the deal.
Comments
Post a Comment